MoviPrep
Is a New Crohn's Disease Treatment on the Horizon? »
"Oct. 17, 2012 -- A drug used to treat psoriasis may provide a much-needed option for people with bad cases of Crohn's disease.
In the new study, some people with moderate to severe Crohn's given Stelara (ustekinumab) began to see imp"...
Read the Is a New Crohn's Disease Treatment on the Horizon? article »
MoviPrep
INDICATIONS
MoviPrep is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older.
DOSAGE AND ADMINISTRATION
The MoviPrep dose for colon cleansing for adult patients is 2 liters (approximately 64 ounces) of MoviPrep solution (with 1 additional liter of clear liquid) taken orally prior to the colonoscopy in one of the following ways:
- Spllt-dose MoviPrep regimen: The evening before the colonoscopy, take the first liter of MoviPrep solution over one hour (one 8 ounce glass every 15 minutes) and then drink 0.5 liters (approximately 16 ounces) of clear liquid. Then, on the morning of the colonoscopy, take the second liter of MoviPrep solution over one hour and then drink 0.5 liters of clear liquid at least one hour prior to the start of the colonoscopy; or
- Evening only (full-dose) MoviPrep regimen: Around 6 PM in the evening before the colonoscopy, take the first liter of MoviPrep solution over one hour (one 8 ounce glass every 15 minutes) and then about 1.5 hours later take the second liter of MoviPrep solution over one hour. In addition, take 1 liter (approximately 32 ounces) of additional clear liquid during the evening before the colonoscopy.
Preparation of the MoviPrep solution
MoviPrep solution is prepared by emptying the contents of 1 pouch A and 1 pouch B into a suitable glass container (or the container provided) and adding to the container 1 liter of lukewarm water. Mix the solution to ensure that the ingredients are completely dissolved. If the patient prefers, the MoviPrep solution can be refrigerated prior to drinking. The reconstituted solution should be used within 24 hours.
No additional ingredients (e.g., flavorings) should be added to the MoviPrep solution.
After consumption of the first liter of MoviPrep solution, the above mixing procedure should be repeated with the second pouch A and pouch B to reconstitute the second liter of the MoviPrep solution.
HOW SUPPLIED
Dosage Forms And Strengths
MoviPrep is available in a carton that contains 4 pouches (2 of pouch A and 2 of pouch B). Each pouch A contains 100 grams of polyethylene glycol (PEG) 3350, NF, 7.5 grams of sodium sulfate,USP, 2.691 grams of sodium chloride, USP, and 1.015 grams of potassium chloride, USP, plus the following excipients: aspartame,NF (sweetener), acesulfame potassium, NF (sweetener), and lemon flavoring. Each pouch B contains 4.7 grams of ascorbic acid, USP and 5.9grams of sodium ascorbate, USP.
Storage And Handling
MoviPrep is supplied as a white to yellow powder. MoviPrep is administered as an oral solution after reconstitution.
NDC 65649-201-75, MoviPrep, single use carton.
NDC 65649-201-76, MoviPrep, professional sample carton.
Each carton contains a disposable container for reconstitution of MoviPrep and 4 pouches (2 of pouch A and 2 of pouch B).
Storage
Store carton/container at 25°C (77°F); excursions permitted to 15- 30°C (59-86°F). When reconstituted, store upright and keep solution refrigerated. Use within 24 hours.
Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. For: Salix Pharmaceuticals, Inc. Raleigh, NC 27615. Revised: Jan 2012
Last reviewed on RxList: 10/5/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional MoviPrep Information
MoviPrep - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
GI Disorders
Get the latest treatment options.






